Explicyte News & Press

Announcements, partnership news, and milestones from Explicyte — what we're building, who we're working with, and where the science is heading.

Explicyte earns ISO 13485 and ISO 9001 certifications for clinical tissue biomarker development & testing in oncology trials

Press release Jun 3, 2026

Explicyte earns ISO 13485 and ISO 9001 certifications for clinical tissue biomarker development & testing in oncology trials

Domain Therapeutics and Explicyte Enter Partnership Agreement in Immuno-Oncology

Press release Mar 10, 2022

Domain Therapeutics and Explicyte Enter Partnership Agreement in Immuno-Oncology

CONDOR Consortium Awarded RHU Funding to Advance Precision Medicine and Immunotherapy in Soft Tissue Sarcomas

Press release Jan 27, 2022

CONDOR Consortium Awarded RHU Funding to Advance Precision Medicine and Immunotherapy in Soft Tissue Sarcomas

Explicyte Becomes a Certified NanoString Partner to Advance Digital Spatial Profiling in Oncology

Press release Dec 10, 2020

Explicyte Becomes a Certified NanoString Partner to Advance Digital Spatial Profiling in Oncology

Explicyte and Institut Bergonié Partner to Advance Translational Immuno-Oncology Research

Press release Mar 25, 2019

Explicyte and Institut Bergonié Partner to Advance Translational Immuno-Oncology Research

Eurostars Grants MODIFY-NK Project to Develop a Novel Modified NK Cell Immunotherapy for Solid Tumours

Press release May 16, 2018

Eurostars Grants MODIFY-NK Project to Develop a Novel Modified NK Cell Immunotherapy for Solid Tumours